´ëÇѽŰæ±ÙÀ°ÁúȯÇÐȸ ¿¬¼ö°Á : 2021-06-12±³À°ÀÏÀÚ : 2021-06-12
±³À°Àå¼Ò : ¿Â¶óÀÎ&¿ÀÇÁ¶óÀÎ º´Çà (*¿ÀÇÁ¶óÀÎ: ºÎ»ê º¤½ºÄÚ ÄÁº¥¼ÇȦ 2Ãþ)
±³À°ÁÖÁ¦ :
(¿Â¶óÀÎ&¿ÀÇÁ¶óÀÎ º´Çà) ´ëÇѽŰæ±ÙÀ°ÁúȯÇÐȸ ¿¬¼ö°ÁÂÁÖÃÖ±â°ü : ´ëÇѽŰæ°úÇÐȸ
½ÃÇà±â°ü(ÁöºÎ/°ú) : ´ëÇѽŰæ±ÙÀ°ÁúȯÇÐȸ
´ã´çÀÚ : ´ëÇѽŰæ±ÙÀ°ÁúȯÇÐȸ »ç¹«±¹
¿¬¶ôó : 02-720-1594
À̸ÞÀÏ :
knmd1594@hanmail.net ±³À°Á¾·ù : ½Å°æ°ú
Âü¼®¿¹»óÀοø : 30¸í
Èñ¸ÁÆòÁ¡ : 3Á¡
Áö¿ª :
ºÎ»ê±¤¿ª½Ã±³À°½Ã°£ : 3 ½Ã°£ 40ºÐ
¼¼ºÎ¼ö°·á : 50,000¿ø
ºñ°í Àü°øÀÇ(ȸ¿ø):1¸¸¿ø / Àü¹®ÀÇ,±âŸ(ȸ¿ø):2¸¸¿ø / ºñȸ¿ø: 5¸¸¿ø
±¸ºÐ ¿ùÀÏ °ÀÇ½Ç ½Ã°£ ±³À°Á¦¸ñ °»ç¸í(¼Ò¼Ó) Çʼö°ú¸ñ
±³À°½Ã°£ 06-12 ºÎ»ê º¤½ºÄÚ ÄÁº¥¼ÇȦ 2Ãþ 09:20~09:50 Basic genetics andnext-generation sequencing application in neuromuscular disease ±è¿µÀº(ÇѾçÀÇ´ëÁø´Ü°Ë»çÀÇÇаú)
±³À°½Ã°£ 06-12 ºÎ»ê º¤½ºÄÚ ÄÁº¥¼ÇȦ 2Ãþ 09:50~10:20 Practical diagnostic approach inmyopathy : Tips to up genetic approach for myopathy in your clinic ÀÌÁ¾¸ñ(°æºÏÀÇ´ë½Å°æ°ú)
±³À°½Ã°£ 06-12 ºÎ»ê º¤½ºÄÚ ÄÁº¥¼ÇȦ 2Ãþ 10:20~10:50 Practical diagnostic approach ininherited motor neuron disease(Hereditary spastic paraplegia(HSP) andspinal muscul aratrophy(SMA)): Tips to up genetic approach for HSP and SMA in your clinic. ÃÖ¼®Áø(¼¿ïÀÇ´ë½Å°æ°ú)
±³À°½Ã°£ 06-12 ºÎ»ê º¤½ºÄÚ ÄÁº¥¼ÇȦ 2Ãþ 10:50~11:30 Gene therapy intransthyretin-mediated amyloidosis (Case-base learning) Lucia Galan(Hospital Clinico San Carlos Spain)
Åä·Ð 06-12 ºÎ»ê º¤½ºÄÚ ÄÁº¥¼ÇȦ 2Ãþ 11:30~11:40 Q & A ¿¬ÀÚ¸ðµÎ()
±³À°½Ã°£ 06-12 ºÎ»ê º¤½ºÄÚ ÄÁº¥¼ÇȦ 2Ãþ 11:50~12:10 EAN/PNS guideline in diagnosis & management of Guillain–Barré syndrome À±º°¾Æ(µ¿¾ÆÀÇ´ë ½Å°æ°ú)
±³À°½Ã°£ 06-12 ºÎ»ê º¤½ºÄÚ ÄÁº¥¼ÇȦ 2Ãþ 12:10~12:30 EAN/PNS guideline in diagnosis & management of chronic inflammatory demyelinating polyneuropathy ±èÁöÀº(ÀÌÈÀÇ´ë ½Å°æ°ú)
±³À°½Ã°£ 06-12 ºÎ»ê º¤½ºÄÚ ÄÁº¥¼ÇȦ 2Ãþ 12:30~13:00 Clinical scales forneuromuscular disorder ±è½Â¿ì(¿¬¼¼ÀÇ´ë ½Å°æ°ú)
Åä·Ð 06-12 ºÎ»ê º¤½ºÄÚ ÄÁº¥¼ÇȦ 2Ãþ 13:00~13:10 Q & A ¿¬ÀÚ¸ðµÎ()